Eletriptan Hydrobromide NDC 24689-167

NDC codes

FDA NDC Directory

Product NDC (as listed)24689-167Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24689-0167Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24689-167-01	24689016701	100 TABLET, FILM COATED in 1 BOTTLE (24689-167-01)Marketed from May 13, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Eletriptan Hydrobromide
Generic name (nonproprietary): eletriptan hydrobromide
Active ingredients: Eletriptan hydrobromide — 20 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Apnar Pharma LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215467
Marketing start: May 13, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 24689-167_bf7e1524-0147-40cf-bd40-5ae994d551a6SPL ID bf7e1524-0147-40cf-bd40-5ae994d551a6SPL set ID 49686c51-bbd9-45f0-92b1-8ffa81612e35RxCUI 359493, 359494UNII M41W832TA3
Pharmacologic class: Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424689016701 followed by a unit qualifier and the quantity

Package 24689-0167-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 19, 2026.

Indications (excerpt from the label)

Eletriptan Hydrobromide Tablets is indicated for the acute treatment of migraine with or without aura in adults. Eletriptan Hydrobromide Tablets is a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults ( 1 ) Limitations of Use: Use only after a clear diagnosis of migraine has been established ( 1 ) Not indicated for the prophylactic therapy of migraine ( 1 ) Not indicated for the treatment of cluster headache ( 1 ) Limitations of Use: Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with Eletriptan Hydrobromide Tablets, reconsider the di…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215467

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215467
Product	Strength	Form · route	Labeler	Product NDC
Eletriptan Hydrobromide	Eletriptan hydrobromide 40 mg/1	Tablet, Film coatedOral	Apnar Pharma LP	24689-168